1. Home
  2. EVTV vs MBIO Comparison

EVTV vs MBIO Comparison

Compare EVTV & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Envirotech Vehicles Inc.

EVTV

Envirotech Vehicles Inc.

HOLD

Current Price

$0.41

Market Cap

2.0M

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$1.12

Market Cap

4.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTV
MBIO
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0M
4.7M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
EVTV
MBIO
Price
$0.41
$1.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.0M
98.0K
Earning Date
11-20-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,696,856.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
113.69
N/A
52 Week Low
$0.40
$0.89
52 Week High
$14.00
$21.95

Technical Indicators

Market Signals
Indicator
EVTV
MBIO
Relative Strength Index (RSI) 15.88 39.03
Support Level $0.75 $1.05
Resistance Level $1.37 $1.31
Average True Range (ATR) 0.13 0.08
MACD -0.07 -0.01
Stochastic Oscillator 1.10 13.88

Price Performance

Historical Comparison
EVTV
MBIO

About EVTV Envirotech Vehicles Inc.

Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: